Patent Assignment
Reel/Frame 072511/0474
Change of Name
Recorded: 2025-08-18
Pages: 3
Assignor
TRAGARA PHARMACEUTICALS, INC.
Executed: 2019-01-23
Assignee
ADASTRA PHARMACEUTICALS, INC.
202 CARNEGIE CENTER, SUITE 104, PRINCETON, NEW JERSEY, 08540
Covered Properties
(2)
Polymorphic Form of TG02 for Treating Cancer
Application:
18/530,745 →
Publication:
US 2024/0254141
Polymorphic Form of TG02 for Treating Cancer
Application:
18/530,765 →
Publication:
US 2024/0254142
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.